Clinical Trial Update: S-1 Versus Capecitabine in the First Line Treatment of MCC Patients. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing S-1 versus Capecitabine as first-line treatment for colorectal cancer with metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Dutch Colorectal Cancer Group | Conditions: Colorectal Cancer, Metastases | Phase 3 | Status: COMPLETED